Tech Company Financing Transactions

BlueWillow Biologics Funding Round

BlueWillow Biologics closed a $12 million Series B funding round on 1/27/2009. Investors included private investors.

Transaction Overview

Announced On
1/27/2009
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2311 Green Rd.
Ann Arbor, MI 48105
USA
Email Address
Not Recorded
Overview
BlueWillow Biologics is a privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines, based on its patented nanotechnology platform.
Profile
BlueWillow Biologics LinkedIn Company Profile
Social Media
BlueWillow Biologics Company Twitter Account
Company News
BlueWillow Biologics News
Facebook
BlueWillow Biologics on Facebook
YouTube
BlueWillow Biologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Peralta
  David Peralta LinkedIn Profile  David Peralta Twitter Account  David Peralta News  David Peralta on Facebook
VP - Bus. Development
David Muth
  David Muth LinkedIn Profile  David Muth Twitter Account  David Muth News  David Muth on Facebook
VP - R & D
Ali Fattom
  Ali Fattom LinkedIn Profile  Ali Fattom Twitter Account  Ali Fattom News  Ali Fattom on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/27/2009: CarrierIQ venture capital transaction
Next: 1/27/2009: SchoolNet venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to record funding rounds that are announced publicly. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary